University of Ioannina
Διερεύνηση πρωτεϊνών ρυθμιστικών του κυτταρικού κύκλου στο πολλαπλό μυέλωμα
Abstract
dc:descriptionA systemic analysis of the immunoexpression of proteins participating in the cyclin D/pRb/p16pathway (cyclins D1, D2, D3, A, B1, E, and proteins p16, pRb) was performed, in 62 bone marrowcore biopsies from newly diagnosed myeloma patients. Protein immunoexpression was correlated a)with each other, b) with Ki67 proliferative activity marker, c) with patient clinicopathologicalparameters, and d) with patient overall survival. Also, cyclin E immunohistochemical expression wasspecified for the first time, in bone marrow core biopsies of newly diagnosed MM cases.Immunoexpression (>10%) was found to be 34%, 42%, 8%, 76%, 29%, and 1.5% for cyclins D1,D2, D3, E, A, and B1 respectively, in newly diagnosed MM cases. These results further supportprevious findings in respect to cyclins D1, D2, D3 and A, while mitotic cyclin B1 immunoexpressionwas found to be very low. In contrast, the great incidence found of cyclin E immunoexpression,indicates high cell numbers in the S phase in MM at diagnosis. Regarding pRb and p16 proteins,their immunoexpression (>10%) incidence in newly diagnosed MM cases, was found to be 68%positively expressing, and 34% negatively expressing, respectively, while a statistically significantpositive correlation was displayed with Ki67 expression (p=0.0008, p=0.0002, respectively). Theseresults, further support that pRb expression in MM is majorly an indicator of its phosphorylatedinactive form. As for p16 protein, p16 methylation seems to be a frequent event like in all previousstudies, although it is not always associated with reduced gene expression. In the present study, astatistically significant positive correlation between cyclin D3 and p27 expression (p=0.002), as wellas a negative correlation between cyclin D3 and p53 expression (p=0.029) was displayed.Furthermore, an almost statistically significant positive correlation (p=0,057) was observed betweenpRb expression and overall survival, which is in agreement with the opinion that monoallelic Rbdeletions do not alter pRb activity. In contrast, no correlation between cyclin D1, D2, D3, A, B1, E,and p16 expression and overall survival could be displayed. Also, a statistically significant positivecorrelation was found a) between cyclin D2 expression and filtration rate, Ca serum levels, B2Mlevels (p=0.006, p=0.0079, p=0.0219), and b) between cyclin D3 expression and creatinine (CRE)levels (p=0.0059), as well as c) a statistically significant negative correlation, between cyclin D2expression and age at diagnosis (p=0.041). From all the above, it is further supported that cyclin D2alone is insufficient for leading to aggressive disease, and that cyclin D3 overexpressing myelomapatients could possibly have a tendency for renal damage more often than in cyclin D3 negativecases.In conclusion, immunohistochemical protein screening, both at diagnosis and during diseaseprogression would have clinical significance, as this would help in MM better understanding as wellas to more targeted therapeutic strategies. Finally, what stands out from this study is the greatincidence of cyclin E immunohistochemical expression, indicating high cell numbers in the S phase inMM at diagnosis.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Πεσσάχ, Ηλίας
- Pessach, Ilias
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29022